https://www.asiannewshub.com/2021/11/indias-covid-19-vaccine-covaxin-found-to-be-77-8-effective-in-phase-3-trial-lancet/
India's COVID-19 vaccine Covaxin found to be 77.8% effective in phase 3 trial: Lancet